Beijing Applied Biological Technologies Co., Ltd. (X-ABT), a molecular diagnostic enterprise specializing in the development of detection solutions for pathogenic microbes, is headquartered in the Zhongguancun Life Science Park in Beijing.
Based on multiplex PCR platform, X-ABT have developed and produced more than 400 types of PCR detection reagent for CDCs and hospitals. In addition, the headquarter of X-ABT are equipped with high end laboratories (Molecular Biology Lab, DNA Sequencing Lab and Immunology Lab) and advanced instruments (Fluorescent PCR platform, Automatic Detection Platform, Freeze Drying Technology Platform, Immunology Technology Platform, Third Generation Sequencing Platform) . Besides, we have been developing genetic testing projects like tumor genetic testing and pharmacogenomics testing.
During years of hardworking and development, X-ABT has achieved several honers and awards. X-ABT was awarded the “High Tech Enterprise” in 2013. The food-borne pathogens multiplex PCR testing system (MPS) have successively won the Beijing new product and new technology excellence award in 2015. The 14 food borne pathogens detection kits and Yersinia enterocolitica detection kits have successively won the Beijing new product and new technology excellence award in 2016. The joint project “establishment and application of a new multiplex PCR detection technology platform” X-ABT cooperated with Institute for Prevention and Control of Viral Diseases of National CDC won the third prize of science and technology award of Chinese Preventive Medicine Association in 2017. X-ABT was endowed with the “Technology R&D Center of Changping,Beijing” and listed as the “Patent Application Pilot Center of Beijing” in 2018. A novel coronavirus nucleic acid detection kit developed by X-ABT was selected as a major item of the Beijing Municipal Science and Technology Commission in 2020.
Company’s Keywords:
<11
<
<